Cobra Biologics signs AstraZeneca deal to supply COVID-19 vaccine

LONDON (Reuters) - Cobra Biologics on Tuesday said it had signed a supply agreement with AstraZeneca to manufacture its COVID-19 vaccine candidate, with a view to a first delivery of the potential vaccine to Britain in September.Cobra is one of the firms that has been working to manufacture the vaccine, which was initially being developed by scientists at the University of Oxford.The vaccine is now known as AZD1222 after AstraZeneca joined forces with the university to develop, produce and..